NCT06028594 Compassionate Use of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria Status NO_LONGER_AVAILABLE Phase N/A
NCT06024408 A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor Status COMPLETED Phase PHASE1
NCT06019481 A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations Status WITHDRAWN Phase N/A
NCT06012448 The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction Status COMPLETED Phase PHASE4
NCT06003881 Compassionate Use of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy Status APPROVED_FOR_MARKETING Phase N/A
NCT05991388 A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma Status RECRUITING Phase PHASE2/PHASE3
NCT05991323 Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05989126 Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS) Status COMPLETED Phase PHASE3
NCT05983068 A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05976386 Single Dose Comparability Study of New and Current Dupilumab Drug Products Subcutaneously Administered in Healthy Adults Status COMPLETED Phase PHASE1
NCT05976373 A Study to Investigate the Pharmacokinetics (PK), Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants. Status COMPLETED Phase PHASE1
NCT05976360 A Study to Investigate the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants Status COMPLETED Phase PHASE1
NCT05970718 A Trial to Learn if Different Doses of REGN7544 Are Safe in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT05961709 The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05955508 A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05929664 Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery Status RECRUITING Phase PHASE2
NCT05923424 A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults Status COMPLETED Phase PHASE1
NCT05906706 Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid Status APPROVED_FOR_MARKETING Phase N/A
NCT05878288 Deep sequencIng in Cutaneous Squamous CEll caRciNomas Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05864144 A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2